# Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee

> **NCT03850587** · PHASE2 · COMPLETED · sponsor: **Yooyoung Pharmaceutical Co., Ltd.** · enrollment: 261 (actual)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DRUG:** Celecoxib 200mg
- **DRUG:** Tramadol 37.5Mg+ Celecoxib 200mg
- **DRUG:** Tramadol 75mg+ Celecoxib 200mg
- **DRUG:** Tramadol 150mg+ Celecoxib 200mg

## Key facts

- **NCT ID:** NCT03850587
- **Lead sponsor:** Yooyoung Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-30
- **Primary completion:** 2020-05-12
- **Final completion:** 2020-09-07
- **Target enrollment:** 261 (ACTUAL)
- **Last updated:** 2021-05-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03850587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03850587, "Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03850587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*